scholarly article | Q13442814 |
P2093 | author name string | Clutter WE | |
Cryer PE | |||
Shah SD | |||
Bier DM | |||
P2860 | cites work | Isotope-derivative measurements of plasma norepinephrine and epinephrine in man | Q22255450 |
Glucagon and plasma catecholamine responses to graded and prolonged exercise in man. | Q33927018 | ||
The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man | Q35902201 | ||
Norepinephrine: hormone and neurotransmitter in man | Q39183968 | ||
Uncontrolled diabetes mellitus and hyperglucagonemia associated with an islet cell carcinoma | Q39316881 | ||
Catecholamines and intermediary metabolism | Q39712237 | ||
Catecholamines and the regulation of hormone secretion | Q39712241 | ||
Hormone-fuel interrelationships during fasting | Q40328913 | ||
In-vivo Measurement of Glucose and Alanine Metabolism with Stable Isotopic Tracers | Q40819450 | ||
Relationship between the plasma glucose level and glucose uptake in the conscious dog | Q43488723 | ||
Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events | Q43530194 | ||
Glucoregulatory responses in normal and diabetic dogs recorded by a new tracer method | Q44627065 | ||
Comparison of competitive protein binding radioassay of cortisol to double isotope dilution and Porter Silber methods | Q47771758 | ||
Stimulation of Glucagon Secretion by Epinephrine in Man | Q47917526 | ||
Measurement of "true" glucose production rates in infancy and childhood with 6,6-dideuteroglucose | Q48252819 | ||
EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN | Q51279822 | ||
Differential effects of epinephrine on glucose production and disposal in man | Q51661488 | ||
Plasma norepinephrine and epinephrine in untreated diabetics, during fasting and after insulin administration. | Q51677016 | ||
Experimental validation of measurements of glucose turnover in nonsteady state | Q52801971 | ||
Measurement of Norepinephrine and Epinephrine in Small Volumes of Human Plasma by a Single Isotope Derivative Method: Response to the Upright Posture | Q53805109 | ||
A microfluorometric enzymatic assay for the determination of alanine and pyruvate in plasma and tissues. | Q54271452 | ||
A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma | Q59064514 | ||
Determination of norepinephrine apparent release rate and clearance in humans | Q63479591 | ||
Studies on the mechanism of epinephrine-induced hyperglycemia in man. Evidence for participation of pancreatic glucagon secretion | Q66904722 | ||
Plasma catecholamines in diabetes. The syndromes of hypoadrenergic and hyperadrenergic postural hypotension | Q67314648 | ||
Plasma catecholamine levels in the coronary sinus, aorta and femoral vein of subjects undergoing cardiac catheterization at rest and during exercise | Q67816951 | ||
A simplified radiometric assay for plasma norepinephrine and epinephrine | Q68659734 | ||
A two-compartment calculator for the dog glucose pool in the nonsteady state | Q69779646 | ||
Enzymic assay of glycerol, dihydroxyacetone, and glyceraldehyde | Q72305592 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | epinephrine | Q28163586 |
hemodynamics | Q1642137 | ||
P304 | page(s) | 94-101 | |
P577 | publication date | 1980-07-01 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. | |
P478 | volume | 66 |
Q72935732 | 10 Phaeochromocytoma |
Q45172764 | Absence of the dawn phenomenon and abnormal lipolysis in type 1 (insulin-dependent) diabetic patients with chronic growth hormone deficiency |
Q36880858 | Accumulation and release of adrenaline, and the modulation by adrenaline of noradrenaline release from rabbit blood vessels in vitro |
Q51434563 | Acute non-traumatic pain increases the hepatic amino- to urea-N conversion in normal man. |
Q51592032 | Adjustment of metabolism, catecholamines and beta-adrenoceptors to 90 min of cycle ergometry. |
Q48398688 | Adrenal epinephrine increases alveolar liquid clearance in a canine model of neurogenic pulmonary edema |
Q72572662 | Adrenaline and Hypertension |
Q37098116 | Advances in biochemical screening for phaeochromocytoma using biogenic amines |
Q42572673 | Analysis of the alpha-adrenoceptor-mediated, and other, components in the sympathetic vasopressor responses of the pithed rat |
Q71974406 | Angiotensin II Augments Reflex Activity of the Sympathetic Nervous System During Cardiopulmonary Resuscitation in Pigs |
Q68437836 | Antagonism of quinidine's electrophysiologic effects by epinephrine in patients with ventricular tachycardia |
Q51245666 | Behavioral and Physiological Effects of Ethanol in High-Risk and Control Children: A Pilot Study |
Q46912415 | Beta-adrenergic blockade restores glucose's antiketogenic activity after exercise in carbohydrate-depleted athletes |
Q34398494 | Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects. |
Q34450261 | Beta-adrenoceptor blockade in stress due to oral surgery |
Q38798203 | Brain-heart interactions: physiology and clinical implications. |
Q44992721 | Cardiohemodynamic and serum catecholamine response to surgical removal of impacted mandibular third molars under local anesthesia: A randomized double-blind parallel group and crossover study |
Q70624778 | Cardiovascular and metabolic responses to submaximal exercise in hemodialysis patients |
Q70696181 | Cardiovascular sensitivity to epinephrine in the trained and untrained states |
Q51733467 | Carotid artery surgery. Local versus general anaesthesia as related to sympathetic activity and cardiovascular effects. |
Q52067411 | Catecholamine clearance is not enhanced by increasing levels within the physiological range. |
Q40905068 | Catecholamines and essential hypertension |
Q45138330 | Chronic β2 adrenergic agonist, but not exercise, improves glucose handling in older type 2 diabetic mice |
Q41130319 | Circulating adrenaline and noradrenaline concentrations during exercise in patients with exercise induced asthma and normal subjects |
Q48001487 | Comparative clinical evaluation of different epinephrine concentrations in 4% articaine for dental local infiltration anesthesia |
Q37364659 | Comparison of the direct and indirect effects of epinephrine on hepatic glucose production |
Q90396753 | Composite Pheochromocytoma Presenting as Severe Lactic Acidosis and Back Pain: A Case Report |
Q70361530 | Concentration effect relationships of infused histamine in normal volunteers |
Q70316113 | Decreased plasma epinephrine concentrations after glucose ingestion in humans |
Q57020709 | Developmental venous anomalies and brainstem cavernous malformations: a proposed physiological mechanism for haemorrhage |
Q34407517 | Diabetic ketoacidosis in a case of pheochromocytoma. |
Q41536383 | Differential blockade of alpha-adrenoceptors by indoramin |
Q35367958 | Differential effects of defibrillation on systemic and cardiac sympathetic activity |
Q72570584 | Direct alpha-adrenergic stimulation of hepatic glucose production in human subjects |
Q34559150 | Direct muscarinic cholinergic inhibition of hepatic glucose production in humans |
Q38683788 | Dobutamine: ten years later |
Q69728546 | Dopamine pharmacokinetics in critically ill newborn infants |
Q52231983 | Dose-response relationship between plasma epinephrine concentration and alveolar liquid clearance in dogs. |
Q35577195 | Early posthypoglycemic insulin resistance in man is mainly an effect of beta-adrenergic stimulation |
Q43796552 | Effect of adrenaline on exchange of glucose in leg tissues and splanchnic area. A comparison with the metabolic response to surgical stress |
Q44142965 | Effect of beta-adrenergic blockade on hormonal responses during continuous and intermittent exercise |
Q34416756 | Effect of beta-adrenoceptor blockade on exercise-induced plasma catecholamine concentrations and their dissipation profile |
Q35580721 | Effect of diabetes on serum potassium concentrations in acute coronary syndromes |
Q42172107 | Effect of short- and long-term beta-adrenergic blockade on lipolysis during fasting in humans |
Q33902911 | Effect of β2-adrenergic receptor polymorphisms on epinephrine and exercise-stimulated lipolysis in humans |
Q50046678 | Effects of KRN2391-induced hypotension on the endocrine system and carbohydrate metabolism in halothane-anesthetized dogs |
Q51728088 | Effects of anesthetics containing epinephrine on catecholamine levels during periodontal surgery. |
Q71870110 | Effects of autonomic stimulation and blockade on signal-averaged P wave duration |
Q39146908 | Effects of catecholamines on secretion of adrenocorticotrophic hormone (ACTH) in man. |
Q44777892 | Effects of dopexamine in comparison with fenoterol on carbohydrate, fat and protein metabolism in healthy volunteers |
Q68498143 | Effects of epinephrine in patients with an accessory atrioventricular connection treated with quinidine |
Q51013554 | Effects of epinephrine on regional free fatty acid and energy metabolism in men and women. |
Q80854772 | Effects of exercise intensity and duration on fat metabolism in trained and untrained older males |
Q52011077 | Effects of increased arterial epinephrine on insulin, glucose and phosphate. |
Q36331844 | Effects of lidocaine with epinephrine on fear related arousal among dental phobics |
Q33912383 | Effects of short-term oral salbutamol administration on exercise endurance and metabolism. |
Q34450076 | Elevated plasma noradrenaline in response to beta-adrenoceptor stimulation in man |
Q33847785 | Elevation of plasma epinephrine concentrations inhibits proteolysis and leucine oxidation in man via beta-adrenergic mechanisms |
Q34182753 | Endocrinology of shock |
Q34629732 | Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epine |
Q72436825 | Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man |
Q37962417 | Epinephrine and the metabolic syndrome |
Q37992521 | Epinephrine in cardiac arrest: a critical review |
Q35204163 | Epinephrine is a hypophosphatemic hormone in man. Physiological effects of circulating epinephrine on plasma calcium, magnesium, phosphorus, parathyroid hormone, and calcitonin |
Q34182136 | Epinephrine is not critical to prevention of hypoglycemia during exercise in humans |
Q42563559 | Epinephrine kinetics in septic shock--a means to understand variable catecholamine efficiency? |
Q37000183 | Epinephrine plasma thresholds for lipolytic effects in man: measurements of fatty acid transport with [l-13C]palmitic acid |
Q70298425 | Epinephrine sensitivity with respect to metabolic rate and other variables in women |
Q34602608 | Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man |
Q71181172 | Epinephrine-induced changes in serum potassium and cardiac repolarization and effects of pretreatment with propranolol and diltiazem |
Q39757063 | Epinephrine: systemic effects and varying concentrations in local anesthesia. |
Q24622140 | Ethanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance |
Q37273001 | Exercise and glycemic control in diabetes: benefits, challenges, and adjustments to pharmacotherapy |
Q43149427 | Exercise-induced increments in plasma levels of propranolol and noradrenaline |
Q34138076 | Factors affecting the plasma insulin concentration shortly after accidental injury in man. |
Q42137733 | Frequency and amplitude enhancement of calcium transients by cyclic AMP in hepatocytes |
Q34519321 | Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion |
Q72502452 | Glucose and urea production and leucine, ketoisocaproate and alanine fluxes at supraphysiological plasma adrenaline concentrations in volunteers |
Q34138744 | Glucose metabolism in children during the first day after burn injury |
Q69406109 | Haemodynamics as a determinant of the pharmacokinetics of and the plasma catecholamine responses to isoprenaline |
Q74452510 | Hepatic and gut clearance of catecholamines in the conscious dog |
Q27310045 | High concentrations of drug in target tissues following local controlled release are utilized for both drug distribution and biologic effect: an example with epicardial inotropic drug delivery |
Q48534132 | Hormonal and cardiovascular variations during a public lecture |
Q35588346 | Hormonal control of substrate cycling in humans |
Q38021881 | Hormonal regulation of protein metabolism |
Q41558005 | Hypokalemia from Beta2-Receptor Stimulation by Circulating Epinephrine |
Q70209555 | Hypokalemia from Beta2-Receptor Stimulation by Epinephrine |
Q41321446 | Improved myocardial oxygen utilization following propranolol infusion in adolescents with postburn hypermetabolism |
Q69378264 | Inhibition by vecuronium of carbachol-induced influx of 22Na+, 45Ca2+ and secretion of catecholamines in cultured bovine adrenal medullary cells |
Q68863738 | Insulin and glucose levels |
Q64951077 | Insulin resistance in alloxan-diabetic dogs: Evidence for reversal following insulin therapy |
Q54401602 | Insulin resistance in type 1 (insulin-dependent) diabetes following hypoglycaemia--evidence for the importance of beta-adrenergic stimulation. |
Q44280868 | Interaction of free fatty acids and epinephrine in regulating hepatic glucose production in conscious dogs |
Q44355151 | Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog. |
Q43590212 | Intravenous cocaine increases plasma epinephrine and norepinephrine in humans |
Q72510756 | Is adrenaline the cause of essential hypertension? |
Q40181621 | Islet function and stress hyperglycemia: plasma glucose and epinephrine interaction |
Q33721562 | Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis |
Q48265527 | Lactate metabolism: historical context, prior misinterpretations, and current understanding. |
Q42079467 | Large-dose epinephrine reduces skeletal muscle blood flow under general anesthesia in rabbits |
Q51764035 | Local dental anaesthesia with lidocaine and adrenaline. Effects on plasma catecholamines, heart rate and blood pressure. |
Q42583428 | Low plasma concentrations of adrenaline and physiological tremor in man. |
Q51558103 | Low-dose epinephrine supports plasma glucose in fasted elderly patients with type 2 diabetes. |
Q36192991 | Maintenance of the postabsorptive plasma glucose concentration: insulin or insulin plus glucagon? |
Q45038500 | Mechanism, temporal patterns, and magnitudes of the metabolic responses to the KATP channel agonist diazoxide |
Q40094892 | Mechanisms of catecholamine effects on ketogenesis |
Q33821886 | Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion |
Q40905060 | Metabolic actions of catecholamines in man. |
Q57420340 | Metabolic heat production and cardiovascular responses to an incremental intravenous infusion of adrenaline in healthy subjects |
Q51581261 | Modified hormonal effects on fat metabolism after severe head injury in children. |
Q33821879 | Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects |
Q28368129 | Nonadrenal epinephrine-forming enzymes in humans. Characteristics, distribution, regulation, and relationship to epinephrine levels |
Q48250698 | Nutrition delivery of a model-based ICU glycaemic control system |
Q40478722 | Opioid Facilitation of β-Adrenergic Blockade: A New Pharmacological Condition? |
Q39633636 | Opioid peptides and metabolic regulation |
Q35843524 | Oral mucosal injection of a local anesthetic solution containing epinephrine enhances muscle relaxant effects of rocuronium |
Q34541402 | Palmitate and glycerol kinetics during brief starvation in normal weight young adult and elderly subjects |
Q45251955 | Patients with Type 1 Diabetes Adapt Acutely to Sustained Mild Hypoglycaemia |
Q68168637 | Perioperative Management of the Diabetic Patient |
Q40184283 | Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies |
Q40589848 | Pharmacokinetics of cardiovascular drugs in children. Inotropes and vasopressors |
Q68898045 | Pharmacokinetics of dopamine in critically ill newborn infants |
Q37360325 | Pharmacokinetics of epinephrine in patients with septic shock: modelization and interaction with endogenous neurohormonal status |
Q30580672 | Pharmacokinetics, hemodynamic and metabolic effects of epinephrine to prevent post-operative low cardiac output syndrome in children |
Q41371186 | Pharmacology of pediatric resuscitation |
Q93878178 | Pheochromocytoma |
Q57420342 | Physiological response to postural change during mild hypoglycaemia in patients with IDDM |
Q34251723 | Physiology and Pathophysiology of the Human Sympathoadrenal Neuroendocrine System |
Q68968548 | Plasma and urinary catecholamines as related to renal function in man |
Q44194789 | Plasma catecholamine concentration during sedation in ventilated patients requiring intensive therapy |
Q42072994 | Plasma catecholamine levels in cyclic antidepressant overdose |
Q22242052 | Plasma catecholamines in the acute phase of the response to myocardial infarction |
Q69881878 | Plasma epinephrine concentration in healthy men: correlation with systolic pressure and rate-pressure product |
Q36344929 | Plasma epinephrine levels and cardiovascular response to high administered doses of epinephrine contained in local anesthesia |
Q43196769 | Plasma free metanephrine, normetanephrine, and 3-methoxytyramine for the diagnosis of pheochromocytoma/paraganglioma |
Q70082813 | Plasma glucagon and catecholamines during exhaustive short-term exercise |
Q43935319 | Postsynaptic alpha 1- and alpha 2-adrenoceptors in human blood vessels: interactions with exogenous and endogenous catecholamines |
Q44302689 | Pulmonary and systemic hemodynamic effects of central venous and left atrial sympathomimetic drug administration in the dog. |
Q58881719 | Quantitative monitoring of brain function, vital signs, and hormonal response during acute insulin-induced hypoglycemia |
Q44302943 | Regulation of lipolysis in severely burned children |
Q45308330 | Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study |
Q67575666 | Relationship between arterial and peripheral venous catecholamine plasma catecholamine concentrations during infusion of noradrenaline and adrenaline in healthy volunteers |
Q42526751 | Relationship between plasma and platelet epinephrine concentrations in humans |
Q44651264 | Respiratory gas-exchange ratios during graded exercise in fed and fasted trained and untrained men. |
Q51604958 | Role of GH in regulating nocturnal rates of lipolysis and plasma mevalonate levels in normal and diabetic humans. |
Q34677271 | Role of epinephrine in acute stress |
Q34627940 | Role of hepatic autoregulation in defense against hypoglycemia in humans |
Q34248284 | Roles of glucagon and epinephrine in hypoglycemic and nonhypoglycemic glucose counterregulation in humans |
Q69259507 | Severe lactic acidosis as a presenting feature of pheochromocytoma |
Q39631351 | Somogyi and dawn phenomena: mechanisms |
Q46218580 | Sources of human urinary epinephrine |
Q47132977 | Strategies for Reducing Fatal Complications in Liposuction |
Q70146090 | Studies on the insulin-antagonistic effect of catecholamines in normal man. Evidence for the importance of beta 2-receptors |
Q41347882 | Support for adrenaline-hypertension hypothesis: 18 hour pressor effect after 6 hours adrenaline infusion |
Q70612951 | Systemic absorption of epinephrine after endoscopic submucosal injection in patients with bleeding peptic ulcers |
Q92432399 | THE EFFECT OF SALBUTAMOL ON PGC-1 α AND GLUT4 mRNA EXPRESSION IN THE LIVER AND MUSCLE OF ELDERLY DIABETIC MICE |
Q39458768 | The association between blood lactate concentration on admission, duration of cardiac arrest, and functional neurological recovery in patients resuscitated from ventricular fibrillation |
Q41032153 | The diabetic patient: a challenge or just routine? |
Q51797131 | The effect of adrenaline in lignocaine anaesthetic solutions on plasma potassium in healthy volunteers. |
Q46693426 | The effect of caffeine on glucose kinetics in humans--influence of adrenaline |
Q51566362 | The effect of stress on the pharmacokinetics and pharmacodynamics of glibenclamide in diabetic rats. |
Q42532104 | The effects of acute or chronic ingestion of propranolol or metoprolol on the metabolic and hormonal responses to prolonged, submaximal exercise in hypertensive men |
Q68074437 | The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and type 1 (insulin-dependent) diabetic humans |
Q38964265 | The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection |
Q54102767 | The effects of epinephrine administration on impedance cardiographic measures of cardiovascular function. |
Q46709965 | The effects of epinephrine in local anesthetics on plasma catecholamine and hemodynamic responses |
Q69924694 | The effects of epinephrine on islet hormone secretion in the dog |
Q33836122 | The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects |
Q46598176 | The effects of race on norepinephrine clearance |
Q51626552 | The impact of body composition on the regulation of lipolysis during short-term fasting. |
Q42079789 | The influence of propranolol on the cardiovascular effects and plasma clearance of epinephrine |
Q51608216 | The metabolic clearance rate of epinephrine in the fetus of the diabetic ewe |
Q40134184 | The neuroendocrine response to multiple trauma |
Q39696805 | The neuroendocrinology of physical injury |
Q36378758 | The origins of cachexia in acute and chronic inflammatory diseases. |
Q67566006 | The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma |
Q33630767 | The stressful condition as a nutritionally dependent adaptive dichotomy |
Q44186927 | Thermogenic response to epinephrine in the forearm and abdominal subcutaneous adipose tissue |
Q42879439 | To beta block or better block? |
Q34275684 | Tolerance to the humoral and hemodynamic effects of caffeine in man. |
Q48478273 | Transforming growth factor-beta in the brain regulates fat metabolism during endurance exercise |
Q24813804 | Treating critical illness: the importance of first doing no harm |
Q40094984 | Use of catecholamines in pediatrics |
Q36147248 | Use of inotropes and vasopressor agents in critically ill patients. |
Q40784932 | Vasoconstrictors in local anesthesia for dentistry |
Q37313030 | Vasopressor requirement during targeted temperature management for out-of-hospital cardiac arrest caused by acute myocardial infarction without cardiogenic shock |
Q68998897 | [Endobronchial administration of adrenaline in cardiopulmonary resuscitation: pharmacokinetic and dynamic studies in the dog] |